[Role of the Blood-Retinal Barrier Transporters: Antiaging in Retina].


Journal

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
ISSN: 1347-5231
Titre abrégé: Yakugaku Zasshi
Pays: Japan
ID NLM: 0413613

Informations de publication

Date de publication:
2021
Historique:
entrez: 2 12 2021
pubmed: 3 12 2021
medline: 19 1 2022
Statut: ppublish

Résumé

Since the retina continuously receives light to enable vision, reactive oxygen species (ROS) are easily generated in neural retina. The oxidative stress induced by ROS may be involved in the onset and progression of blinding aging diseases such as age-related macular degeneration, diabetic retinopathy, and glaucoma. Although supply of antioxidants to the retina is important to maintain the redox homeostasis in neural retina, the blood-retinal barrier (BRB) is created by complex tight-junctions of retinal capillary endothelial cells and retinal pigment epithelial cells to prevent the free diffusion of substances. The BRB is equipped with several membrane transporters to supply nutrients and essential molecules including antioxidants and drugs which exhibit antiaging effect to the retina from the circulating blood. In this review, the transporter-mediated retinal distribution of key endogenous compounds and drugs, such as vitamin C, l-cystine and gabapentin, is introduced for antiaging of the retina.

Identifiants

pubmed: 34853204
doi: 10.1248/yakushi.21-00158-2
doi:

Substances chimiques

Antioxidants 0
Reactive Oxygen Species 0
Cystine 48TCX9A1VT
Gabapentin 6CW7F3G59X
Ascorbic Acid PQ6CK8PD0R

Types de publication

Journal Article Review

Langues

jpn

Sous-ensembles de citation

IM

Pagination

1319-1325

Auteurs

Ken-Ichi Hosoya (KI)

Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.

Shin-Ichi Akanuma (SI)

Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.

Yoshiyuki Kubo (Y)

Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH